Imbruvica 140 Mg Capsules

Imbruvica 140 mg Capsules contains the active ingredient ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor designed to impede the proliferation of cancer cells. It is primarily prescribed for the treatment of mantle-cell lymphoma and chronic lymphocytic leukemia.

Uses:

• Mantle-Cell Lymphoma: A type of non-Hodgkin’s lymphoma characterized by malignant B-cells.
• Chronic Lymphocytic Leukemia (CLL): A slow-progressing cancer of the bone marrow and blood.

Dosage and Administration:

The specific dosage and duration of Imbruvica treatment are determined by a healthcare professional based on the patient’s medical condition. It is recommended to take the capsule at the same time each day, with or without food.

Common Side Effects:

• Headache
• Fever
• Diarrhea
• Stomatitis (inflammation of the mouth)
• Nausea
• Low blood platelets
• Decreased white blood cell count (neutrophils)
• Fatigue
• Musculoskeletal pain
• Rash
• Anemia
• Bruising
• Muscle spasm
• Hemorrhage
• Pneumonia
• Cough
• Dry eye
• High blood pressure
• Weight loss
• Urinary tract infection
• Peripheral edema
• Subdural hematoma
• Second primary malignancies

Safety Advice:

• Alcohol: Consult your doctor regarding alcohol consumption during treatment.
• Pregnancy: Not recommended due to potential risks to the developing baby.
• Breastfeeding: Use with caution; breastfeeding should be paused until the drug is eliminated from the body.
• Driving: May cause side effects that could impair driving ability.
• Kidney and Liver Health: Patients with kidney or liver disease should use Imbruvica cautiously, with possible dose adjustments.

Available Substitutes:

• Nitib 140 mg Capsule by Hetero Healthcare Limited
• Ibrunat 140 mg Capsule by Natco Pharma Limited
• Ibrushil 140 mg Capsule by Shilpa Medicare Ltd
• Tybriva Capsule by Emcure Pharmaceuticals Ltd

These alternatives may offer cost-effective options; however, consult your healthcare provider before making any changes to your medication regimen.

Quick Tips:

• Maintain consistent daily dosing.
• Stay hydrated during treatment.
• Complete the full course as prescribed.
• Use effective birth control to prevent pregnancy during treatment.
• Regular blood tests may be necessary to monitor liver function and blood cell counts.

Conclusion:

Imbruvica 140 mg Capsule is a targeted therapy for certain types of blood cancers, offering a mechanism to inhibit cancer cell growth. Patients should adhere strictly to their healthcare provider’s instructions and report any side effects or concerns promptly to ensure optimal treatment outcomes.